Stunting is associated with poor outcomes in childhood pneumonia

Peter P Moschovis1, Emmanuel O D Addo-Yobo2, Salem Banajeh3

  • 1Massachusetts General Hospital, Boston, MA, USA.

Insights

Childhood stunting significantly increases pneumonia treatment failure and prolongs recovery. Addressing stunting in low-resource settings may improve pneumonia outcomes.

Area of Science:

  • Pediatric infectious diseases
  • Global child health
  • Nutritional epidemiology

Background:

  • Stunting affects over a quarter of children globally, with unknown impacts on childhood pneumonia outcomes.
  • Childhood pneumonia remains a leading cause of mortality in low- and middle-income countries (LMICs).

Purpose of the Study:

  • To evaluate the impact of stunting on treatment outcomes and recovery time in children with pneumonia.
  • To analyze data from two large clinical trials involving children with severe and amoxicillin-treated pneumonia.

Main Methods:

  • Analysis of data from 2542 children (aged 2-59 months) across 16 LMIC sites in two WHO/USAID-sponsored trials.
  • Stunting defined as height-for-age Z-score < -2. Assessed treatment failure by day 5 and time to resolution of hypoxemic pneumonia.

Main Results:

  • 28% of children were stunted. Stunted children had a higher treatment failure rate (16.0% vs. 11.5%).
  • Stunting was associated with increased risk of treatment failure (adjusted RR 1.28).
  • Among hypoxemic pneumonia patients, stunting correlated with slower normalization of respiratory rate and oxygen saturation.

Conclusions:

  • Stunting is a significant risk factor for increased pneumonia treatment failure and prolonged recovery in children.
  • Interventions to reduce childhood stunting could mitigate adverse pneumonia outcomes in resource-limited settings.
Abstract

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.0K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Nature and Nurture01:10

Nature and Nurture

Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
22.9K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.3K